|
September 07
Dow
AgroSciences and Exelixis Plant Sciences announce major research
collaboration, asset purchase to advance gene discovery and
validation
October 03
Exelixis identifies
mechanism of action, target of key herbicidal compound for Dow
AgroSciences
August 03
Exelixis and Dow
AgroSciences extend research collaboration
June 03
Exelixis appoints Steven P.
James to head commercial operations
May 03
Exelixis announces first
quarter 2003 financial results
February 03
Exelixis announces
fourth quarter and year-end 2002 financial results
January 03
Agrinomics identifies new
genetic mechanisms that control plant resistance to fungal infection
December 02
Agrinomics and Renessen
establish alliance to enhance seed oil content
July 02
Exelixis delivers assays to
Bayer CropScience for screening to identify novel crop protection
compounds
Exelixis identifies
mechanism of action, target of key herbicidal compound for Dow
AgroSciences
April 02
Exelixis delivers
novel crop protection targets to Bayer through Genoptera joint
venture
Bayer and Exelixis
joint venture, Genoptera, is first to sequence Heliothis moth genome --
achievement advances goal of developing safe, more innovative
insecticides
January 02
Exelixis identifies
additional crop protection targets delivered to Bayer through Genoptera
joint venture
November 01
Dow AgroSciences and
Exelixis achieve milestones in discovery collaboration -- Four targets
identified in new approach to crop protection
Exelixis announces third
quarter financial results
September 01
Exelixis Plant Sciences
receives National Science Foundation award for gene discovery to improve
rice
August 01
Additional milestones
reached by Exelixis in joint venture with Bayer
Exelixis announces
second quarter financial results
July 01
Exelixis/Bayer joint
venture Genoptera identifies new genomics-based pesticide targets
May
01
Exelixis
achieves research milestone in Bayer joint venture
March
01
Exelixis
delivers more novel targets to Bayer in Genoptera joint venture
December
00
Exelixis
completes acquisition of Agritope
November
00
Exelixis
delivers several targets to Bayer through Genoptera joint venture
October
00
Exelixis
delivers two assays for high throughput screening to Bayer In Genoptera
joint venture
September
00
Exelixis
to acquire key plant technology, intellectual property and plant
biology capabilities through acquisition of Agritope
August
00
Exelixis
and Bayer reach milestones in Genoptera joint venture - Several novel
insecticide targets selected
April 99
Exelixis
Pharmaceuticals delivers target for screening to Bayer AG as part of genetics research
alliance
May 98
Exelixis Pharmaceuticals and Bayer AG sign
genetics research alliance - Exelixis' expertise in model organism genetics to accelerate
identification of novel targets for crop protection
|
